Although IHC evaluation of the ATF6 and ATF6B in lung cancer tissues vs. case-matched non-cancerous tissues is somewhat inconclusive, the overall survival analysis for the lung cancer patients unraveled an opposite prognostic value between ATF6 and ATF6B. This evidence concerns the gene ATF6B and lung carcinoma.